Vitamin Shoppe (VSI) Misses Q2 EPS by 16c, Miss on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 hits record high as rate-hike worries ease
- Oil pares losses after reports Houthis attacked Saudi Aramco refinery
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Burry doubles down on Nebius short after stock surges 34% on earnings
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Home Depot CEO Ted Decker takes medical leave; two executives step in
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Vitamin Shoppe (VSI) PT Lowered to $6 at Barclays
August 10, 2017 9:10 AM EDTBarclays lowered its price target on Vitamin Shoppe (NYSE: VSI) to $6.00 (from $13.00) while maintaining a Equalweight rating.
... MoreVitamin Shoppe (VSI) PT Lowered to $6 at Goldman Sachs
August 10, 2017 6:47 AM EDTGoldman Sachs lowered its price target on Vitamin Shoppe (NYSE: VSI) to $6.00 (from $13.00) while maintaining a Sell rating.
Analyst Stephen Tanal expects competitive pressure to persist. The analyst reminds clients that mass merchants, grocers, drug stores and online retail shave all been... More
